Protective Role of Foot-and-Mouth Disease Virus Antibody in vitro and in vivo in Guinea-pigs

References

1. Benacerraf B., Sebestyin M., Cooper N. S. 1959; The clearance of antigen-antibody complexes from the blood by the reticulo-endothelial system. Journal of Immunology 82:131–137
   [Google Scholar]
2. Booth J. C. 1977; Enhancement by diethylamino ethyl-dextran of the plaque forming activity of foot-and-mouth disease virus-antibody complexes in pig kidney 1B-RS-2 cells. Archives of Virology 55:251–261
   [Google Scholar]
3. Cowan K. M., Trautman R. 1965; Antibodies produced by guinea pigs infected with foot-and-mouth disease virus. Journal of Immunology 94:858–867
   [Google Scholar]
4. Cunliffe H. R., Graves J. H. 1963; Formalin treated foot-and-mouth virus: comparison of two adjuvants in cattle. Canadian Journal of Comparative Medicine and Veterinary Science 27:193–197
   [Google Scholar]
5. Dinka S. K., Swaney L. M., McVicar J. W. 1977; Selection of a stable clone of the MVPK-1 fetal porcine kidney cell for assays of foot-and-mouth disease virus. Canadian Journal of Microbiology 23:295–299
   [Google Scholar]
6. Finney D. I. 1964 Statistical Methods in Biological Assay 2nd edn. pp 524–533 New York: Hafner Publishing Company;
   [Google Scholar]
7. Hahon N. 1970; Neutralization of residual infectivity of Venezuelan equine encephalomyelitis virus by antigamma globulin. Journal of General Virology 6:361–372
   [Google Scholar]
8. Hardy M. M., Moore D. M. 1981; Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit. Journal of General Virology 55:415–427
   [Google Scholar]
9. Knudsen R. C., Groocock C. M., Andersen A. A. 1979; Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses. Infection and Immunity 24:787–792
   [Google Scholar]
10. Knudsen R. C., Groocock C. M., Andersen A. A. 1982; Difference in protective immunity of the tongue and feet of guinea pigs vaccinated with foot-and-mouth disease virus type A₁₂ following intradermolingual and footpad challenge. Veterinary Microbiology 7:97–107
    [Google Scholar]
11. Mackowiak C., Fontaine J., Terre J., Stellmann C., Roumiantzeff M., Petermann H. G. 1966; Controle quantitatif du vaccin antiaphteux. Etudi de la loi dose-effet et correlation entre les doses vaccinantes 50 p. 100 chez les cobayes et les bovides. Bulletin de l’office international des épizooties 65:131–171
    [Google Scholar]
12. McVicar J. W., Sutmoller P., Andersen A. A. 1974; Foot-and-mouth disease virus: plaque reduction neutralization test. Archiv für die gesamte Virusforschung 44:168–172
    [Google Scholar]
13. Massey R. J., Schochetman G. 1981; Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. Science 213:447–449
    [Google Scholar]
14. Munthe-Kaas A. C., Kaplan G., Seljelid R. 1976; On the mechanism of internalization of opsonized particles by rat peritoneal Kupffer cells in vitro. Experimental Cell Research 103:201–212
    [Google Scholar]
15. Phillips-Quagliata J. M., Levine B. B., Quagliata F., Uhr J. W. 1971; Mechanisms underlying binding of immune complexes to macrophages. Journal of Experimental Medicine 133:589–601
    [Google Scholar]
16. Skinner H. H. 1951; Propagation of strains of foot-and-mouth disease virus in unweaned white mice. Proceedings of the Royal Society of Medicine 44:15–18
    [Google Scholar]
17. Terpstra C., Frenkel S., Straver P. J., Barteling S. J., van Bekkum J. G. 1976; Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines. Veterinary Microbiology 1:71–83
    [Google Scholar]